Cargando…
A Prototype Recombinant-Protein Based Chlamydia pecorum Vaccine Results in Reduced Chlamydial Burden and Less Clinical Disease in Free-Ranging Koalas (Phascolarctos cinereus)
Diseases associated with Chlamydia pecorum infection are a major cause of decline in koala populations in Australia. While koalas in care can generally be treated, a vaccine is considered the only option to effectively reduce the threat of infection and disease at the population level. In the curren...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710501/ https://www.ncbi.nlm.nih.gov/pubmed/26756624 http://dx.doi.org/10.1371/journal.pone.0146934 |
_version_ | 1782409809932320768 |
---|---|
author | Waugh, Courtney Khan, Shahneaz Ali Carver, Scott Hanger, Jonathan Loader, Joanne Polkinghorne, Adam Beagley, Kenneth Timms, Peter |
author_facet | Waugh, Courtney Khan, Shahneaz Ali Carver, Scott Hanger, Jonathan Loader, Joanne Polkinghorne, Adam Beagley, Kenneth Timms, Peter |
author_sort | Waugh, Courtney |
collection | PubMed |
description | Diseases associated with Chlamydia pecorum infection are a major cause of decline in koala populations in Australia. While koalas in care can generally be treated, a vaccine is considered the only option to effectively reduce the threat of infection and disease at the population level. In the current study, we vaccinated 30 free-ranging koalas with a prototype Chlamydia pecorum vaccine consisting of a recombinant chlamydial MOMP adjuvanted with an immune stimulating complex. An additional cohort of 30 animals did not receive any vaccine and acted as comparison controls. Animals accepted into this study were either uninfected (Chlamydia PCR negative) at time of initial vaccination, or infected (C. pecorum positive) at either urogenital (UGT) and/or ocular sites (Oc), but with no clinical signs of chlamydial disease. All koalas were vaccinated / sampled and then re-released into their natural habitat before re-capturing and re-sampling at 6 and 12 months. All vaccinated koalas produced a strong immune response to the vaccine, as indicated by high titres of specific plasma antibodies. The incidence of new infections in vaccinated koalas over the 12-month period post-vaccination was slightly less than koalas in the control group, however, this was not statistically significant. Importantly though, the vaccine was able to significantly reduce the infectious load in animals that were Chlamydia positive at the time of vaccination. This effect was evident at both the Oc and UGT sites and was stronger at 6 months than at 12 months post-vaccination. Finally, the vaccine was also able to reduce the number of animals that progressed to disease during the 12-month period. While the sample sizes were small (statistically speaking), results were nonetheless striking. This study highlights the potential for successful development of a Chlamydia vaccine for koalas in a wild setting. |
format | Online Article Text |
id | pubmed-4710501 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-47105012016-01-26 A Prototype Recombinant-Protein Based Chlamydia pecorum Vaccine Results in Reduced Chlamydial Burden and Less Clinical Disease in Free-Ranging Koalas (Phascolarctos cinereus) Waugh, Courtney Khan, Shahneaz Ali Carver, Scott Hanger, Jonathan Loader, Joanne Polkinghorne, Adam Beagley, Kenneth Timms, Peter PLoS One Research Article Diseases associated with Chlamydia pecorum infection are a major cause of decline in koala populations in Australia. While koalas in care can generally be treated, a vaccine is considered the only option to effectively reduce the threat of infection and disease at the population level. In the current study, we vaccinated 30 free-ranging koalas with a prototype Chlamydia pecorum vaccine consisting of a recombinant chlamydial MOMP adjuvanted with an immune stimulating complex. An additional cohort of 30 animals did not receive any vaccine and acted as comparison controls. Animals accepted into this study were either uninfected (Chlamydia PCR negative) at time of initial vaccination, or infected (C. pecorum positive) at either urogenital (UGT) and/or ocular sites (Oc), but with no clinical signs of chlamydial disease. All koalas were vaccinated / sampled and then re-released into their natural habitat before re-capturing and re-sampling at 6 and 12 months. All vaccinated koalas produced a strong immune response to the vaccine, as indicated by high titres of specific plasma antibodies. The incidence of new infections in vaccinated koalas over the 12-month period post-vaccination was slightly less than koalas in the control group, however, this was not statistically significant. Importantly though, the vaccine was able to significantly reduce the infectious load in animals that were Chlamydia positive at the time of vaccination. This effect was evident at both the Oc and UGT sites and was stronger at 6 months than at 12 months post-vaccination. Finally, the vaccine was also able to reduce the number of animals that progressed to disease during the 12-month period. While the sample sizes were small (statistically speaking), results were nonetheless striking. This study highlights the potential for successful development of a Chlamydia vaccine for koalas in a wild setting. Public Library of Science 2016-01-12 /pmc/articles/PMC4710501/ /pubmed/26756624 http://dx.doi.org/10.1371/journal.pone.0146934 Text en © 2016 Waugh et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Waugh, Courtney Khan, Shahneaz Ali Carver, Scott Hanger, Jonathan Loader, Joanne Polkinghorne, Adam Beagley, Kenneth Timms, Peter A Prototype Recombinant-Protein Based Chlamydia pecorum Vaccine Results in Reduced Chlamydial Burden and Less Clinical Disease in Free-Ranging Koalas (Phascolarctos cinereus) |
title | A Prototype Recombinant-Protein Based Chlamydia pecorum Vaccine Results in Reduced Chlamydial Burden and Less Clinical Disease in Free-Ranging Koalas (Phascolarctos cinereus) |
title_full | A Prototype Recombinant-Protein Based Chlamydia pecorum Vaccine Results in Reduced Chlamydial Burden and Less Clinical Disease in Free-Ranging Koalas (Phascolarctos cinereus) |
title_fullStr | A Prototype Recombinant-Protein Based Chlamydia pecorum Vaccine Results in Reduced Chlamydial Burden and Less Clinical Disease in Free-Ranging Koalas (Phascolarctos cinereus) |
title_full_unstemmed | A Prototype Recombinant-Protein Based Chlamydia pecorum Vaccine Results in Reduced Chlamydial Burden and Less Clinical Disease in Free-Ranging Koalas (Phascolarctos cinereus) |
title_short | A Prototype Recombinant-Protein Based Chlamydia pecorum Vaccine Results in Reduced Chlamydial Burden and Less Clinical Disease in Free-Ranging Koalas (Phascolarctos cinereus) |
title_sort | prototype recombinant-protein based chlamydia pecorum vaccine results in reduced chlamydial burden and less clinical disease in free-ranging koalas (phascolarctos cinereus) |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710501/ https://www.ncbi.nlm.nih.gov/pubmed/26756624 http://dx.doi.org/10.1371/journal.pone.0146934 |
work_keys_str_mv | AT waughcourtney aprototyperecombinantproteinbasedchlamydiapecorumvaccineresultsinreducedchlamydialburdenandlessclinicaldiseaseinfreerangingkoalasphascolarctoscinereus AT khanshahneazali aprototyperecombinantproteinbasedchlamydiapecorumvaccineresultsinreducedchlamydialburdenandlessclinicaldiseaseinfreerangingkoalasphascolarctoscinereus AT carverscott aprototyperecombinantproteinbasedchlamydiapecorumvaccineresultsinreducedchlamydialburdenandlessclinicaldiseaseinfreerangingkoalasphascolarctoscinereus AT hangerjonathan aprototyperecombinantproteinbasedchlamydiapecorumvaccineresultsinreducedchlamydialburdenandlessclinicaldiseaseinfreerangingkoalasphascolarctoscinereus AT loaderjoanne aprototyperecombinantproteinbasedchlamydiapecorumvaccineresultsinreducedchlamydialburdenandlessclinicaldiseaseinfreerangingkoalasphascolarctoscinereus AT polkinghorneadam aprototyperecombinantproteinbasedchlamydiapecorumvaccineresultsinreducedchlamydialburdenandlessclinicaldiseaseinfreerangingkoalasphascolarctoscinereus AT beagleykenneth aprototyperecombinantproteinbasedchlamydiapecorumvaccineresultsinreducedchlamydialburdenandlessclinicaldiseaseinfreerangingkoalasphascolarctoscinereus AT timmspeter aprototyperecombinantproteinbasedchlamydiapecorumvaccineresultsinreducedchlamydialburdenandlessclinicaldiseaseinfreerangingkoalasphascolarctoscinereus AT waughcourtney prototyperecombinantproteinbasedchlamydiapecorumvaccineresultsinreducedchlamydialburdenandlessclinicaldiseaseinfreerangingkoalasphascolarctoscinereus AT khanshahneazali prototyperecombinantproteinbasedchlamydiapecorumvaccineresultsinreducedchlamydialburdenandlessclinicaldiseaseinfreerangingkoalasphascolarctoscinereus AT carverscott prototyperecombinantproteinbasedchlamydiapecorumvaccineresultsinreducedchlamydialburdenandlessclinicaldiseaseinfreerangingkoalasphascolarctoscinereus AT hangerjonathan prototyperecombinantproteinbasedchlamydiapecorumvaccineresultsinreducedchlamydialburdenandlessclinicaldiseaseinfreerangingkoalasphascolarctoscinereus AT loaderjoanne prototyperecombinantproteinbasedchlamydiapecorumvaccineresultsinreducedchlamydialburdenandlessclinicaldiseaseinfreerangingkoalasphascolarctoscinereus AT polkinghorneadam prototyperecombinantproteinbasedchlamydiapecorumvaccineresultsinreducedchlamydialburdenandlessclinicaldiseaseinfreerangingkoalasphascolarctoscinereus AT beagleykenneth prototyperecombinantproteinbasedchlamydiapecorumvaccineresultsinreducedchlamydialburdenandlessclinicaldiseaseinfreerangingkoalasphascolarctoscinereus AT timmspeter prototyperecombinantproteinbasedchlamydiapecorumvaccineresultsinreducedchlamydialburdenandlessclinicaldiseaseinfreerangingkoalasphascolarctoscinereus |